To assess the potential ac4C-regulated mRNA targets modified by NAT10 in HNSCC, acRIP-sequencing (acRIP-seq) assays were performed using mRNA isolated from shNC and shNAT10 FaDu cell lines. This evidence concerns the gene NAT10 and head and neck squamous cell carcinoma.